Loblaw Companies Limited released Q1 results ending March 22, 2025, this week.
Revenues were $14.13 billion, an increase of $554 million, while retail segment sales were $13.83 billion an increase of $547 million. Food retail (Loblaw) same-store sales grew by 2.2 percent while drug retail (Shoppers Drug Mart) same-store sales increased by 3.8 percent, with pharmacy and healthcare services same-store sales growth of 6.4 percent and front store same-store sales growth of 0.9 percent.
E-commerce grew sharply this quarter increasing 17.4 percent. In a statement the company noted that it plans to open approximately 80 new stores and 100 new clinics in 2025.
“We will continue to support Canadian companies and brands, highlight Canadian-made products in our stores, and deliver value across our network,” said Per Bank, president and CEO of Loblaw Cos. Ltd. “Our commitment to retail excellence is resonating with customers and allowed us to deliver consistent financial results.”
